RaPiD-mAb-MS™ Reagent Kits

Built-In Cleanup, Maximum Throughput

Our standard 96-well format kits are compatible with both bench pipetting and automated liquid handlers. They include digestion enzymes and proprietary chemistry that seamlessly remove excipients, sugars, and surfactants, eliminating the need for tedious desalting steps. Best of all, every kit purchase includes the software needed for comprehensive data analysis – no additional costs or licenses required.

RaPiD-Analyze™ Software

Automated Data Analysis, Zero Licensing Fees

RaPiD-Analyze™ software automates the entire process—from generating the instrument method files to analyzing the infusion spectra and quantifying Critical Quality Attributes (CQAs). Highly interactive data viewing and reporting tools allow you to easily compare data across multiple antibodies. To ensure a seamless, plug-and-play experience, full access to RaPiD-Analyze™ is automatically included with every reagent kit. By eliminating separate software licenses, we provide a transparent, all-in-one solution.

Millipore Sigma

The ability to acquire peptide mapping data in just 1-2 minutes while maintaining high sequence coverge is remarkable. The CeleramAb team has been extremely responsive and supportive throughout onboarding and implementation, with an exceptional level of customer engagement and technical support.

Pei Liu
Principal Scientist

Johnson & Johnson

The RaPiD-mAb-MS platform™ eliminates the traditional chromatography bottleneck, allowing us to screen and characterize antibodies at a scale and speed that were previously unattainable.

Harsha Gunawardena, PhD
Proteomics Group Leader
Johnson & Johnson Innovative Medicine

Top 5 Biopharma

In early development, turnaround time is critical. The RaPiD-mAb-MS™ platform’s ability to eliminate the liquid chromatography bottleneck allows us to generate deep, high-quality peptide mapping data in a fraction of the time, accelerating our ability to return actionable insights to our design teams.

Associate Director
Top 5 Biopharma